78 related articles for article (PubMed ID: 7576326)
1. HIV infection and invasive cervical carcinoma in an Italian population: the need for closer screening programmes in seropositive patients.
Zanetta G; Maneo A; Colombo A; Ragusa A; Gabriele A; Placa F; Mangioni C
AIDS; 1995 Aug; 9(8):909-12. PubMed ID: 7576326
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.
Abdullahi A; Mustapha MI; David DA; Ayodeji OT
Ann Afr Med; 2018; 17(1):17-21. PubMed ID: 29363631
[TBL] [Abstract][Full Text] [Related]
3. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
[TBL] [Abstract][Full Text] [Related]
8. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
[TBL] [Abstract][Full Text] [Related]
9. The value of cervical cytology in HIV-infected women.
Del Priore G; Maag T; Bhattacharya M; Garcia PM; Till M; Lurain JR
Gynecol Oncol; 1995 Mar; 56(3):395-8. PubMed ID: 7705674
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.
Alldredge J; Leaf MC; Patel P; Coakley K; Longoria T; McLaren C; Randall LM
Int J Gynecol Cancer; 2020 Jun; 30(6):772-776. PubMed ID: 32156714
[TBL] [Abstract][Full Text] [Related]
11. Audit of cervical screening in women with HIV infection in the Auckland and Northland regions of New Zealand.
Grewal J; Lowe M; Gerrard H; Henley R; Perkins N; Briggs S
N Z Med J; 2010 Jul; 123(1319):71-8. PubMed ID: 20717179
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus infection and invasive cervical carcinoma.
Maiman M; Fruchter RG; Guy L; Cuthill S; Levine P; Serur E
Cancer; 1993 Jan; 71(2):402-6. PubMed ID: 8093678
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
14. Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection.
Laga M; Icenogle JP; Marsella R; Manoka AT; Nzila N; Ryder RW; Vermund SH; Heyward WL; Nelson A; Reeves WC
Int J Cancer; 1992 Jan; 50(1):45-8. PubMed ID: 1309459
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell cervical lesions in women with and without AIDS. Biochemical risk factors, prevention, and policy.
Lovejoy NC; Anastasi JK
Cancer Nurs; 1994 Aug; 17(4):294-307. PubMed ID: 7954377
[TBL] [Abstract][Full Text] [Related]
16. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
Batra P; Kuhn L; Denny L
S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
[TBL] [Abstract][Full Text] [Related]
17. [Cervical and breast cancer screening among immigrant women resident in Italy].
Francovich L; Di Napoli A; Giorgi Rossi P; Gargiulo L; Giordani B; Petrelli A
Epidemiol Prev; 2017; 41(3-4 (Suppl 1)):18-25. PubMed ID: 28929723
[TBL] [Abstract][Full Text] [Related]
18. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome.
Shrivastava SK; Engineer R; Rajadhyaksha S; Dinshaw KA
Radiother Oncol; 2005 Jan; 74(1):31-5. PubMed ID: 15683666
[TBL] [Abstract][Full Text] [Related]
19. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
20. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
